Catalyst Wire Dossier Catalyst Wire Dossier

MULPLETA

lusutrombopag · Eddingpharm (U. S. ) Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MULPLETA, covering 2018-07-31 to 2018-07-31. Get the full timeline:

Most recent: FDA Approved: MULPLETA — Original Application (Eddingpharm (U. S. ) Inc.)

See pricing